Nephros Inc
Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. The company offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and p… Read more
Market Cap & Net Worth: Nephros Inc (NEPH)
Nephros Inc (NASDAQ:NEPH) has a market capitalization of $32.46 Million ($32.46 Million) as of March 19, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #23697 globally and #8252 in its home market, demonstrating a -25.31% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Nephros Inc's stock price $3.06 by its total outstanding shares 10626683 (10.63 Million).
Nephros Inc Market Cap History: 2015 to 2026
Nephros Inc's market capitalization history from 2015 to 2026. Data shows change from $20.61 Million to $32.46 Million (-0.83% CAGR).
Index Memberships
Nephros Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.20 Trillion | 0.00% | #634 of 976 |
|
NASDAQ Composite
IXIC
|
$32.97 Trillion | 0.00% | #2080 of 3165 |
Weight: Nephros Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Nephros Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Nephros Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
2.76x
Nephros Inc's market cap is 2.76 times its annual revenue
169.88x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
43.43x
Nephros Inc's market cap is 43.43 times its annual earnings
830.37x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $35.01 Million | $2.32 Million | -$3.03 Million | 15.09x | N/A |
| 2017 | $43.05 Million | $3.81 Million | -$809.00K | 11.30x | N/A |
| 2018 | $54.51 Million | $5.69 Million | -$3.40 Million | 9.59x | N/A |
| 2019 | $105.74 Million | $10.33 Million | -$3.42 Million | 10.23x | N/A |
| 2020 | $91.18 Million | $8.56 Million | -$4.77 Million | 10.65x | N/A |
| 2021 | $62.70 Million | $10.22 Million | -$4.11 Million | 6.14x | N/A |
| 2022 | $12.30 Million | $9.97 Million | -$7.38 Million | 1.23x | N/A |
| 2023 | $36.77 Million | $14.24 Million | -$1.57 Million | 2.58x | N/A |
| 2024 | $15.62 Million | $14.16 Million | $74.00K | 1.10x | 211.10x |
| 2025 | $51.86 Million | $18.79 Million | $1.19 Million | 2.76x | 43.43x |
Competitor Companies of NEPH by Market Capitalization
Companies near Nephros Inc in the global market cap rankings as of March 19, 2026.
Key companies related to Nephros Inc by market ranking:
- Intuitive Surgical Inc (NASDAQ:ISRG): Ranked #98 globally with a market cap of $168.62 Billion USD.
- EssilorLuxottica Société anonyme (PINK:ESLOF): Ranked #261 globally with a market cap of $78.22 Billion USD.
- EssilorLuxottica S. A. (PA:EL): Ranked #358 globally with a market cap of $61.21 Billion USD ( €59.64 Billion EUR).
- Becton Dickinson and Company (NYSE:BDX): Ranked #481 globally with a market cap of $44.89 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #98 | Intuitive Surgical Inc | NASDAQ:ISRG | $168.62 Billion | $477.73 |
| #261 | EssilorLuxottica Société anonyme | PINK:ESLOF | $78.22 Billion | $265.00 |
| #358 | EssilorLuxottica S. A. | PA:EL | $61.21 Billion | €203.10 |
| #481 | Becton Dickinson and Company | NYSE:BDX | $44.89 Billion | $158.08 |
Nephros Inc Historical Marketcap From 2015 to 2026
Between 2015 and today, Nephros Inc's market cap moved from $20.61 Million to $ 32.46 Million, with a yearly change of -0.83%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $32.46 Million | -37.40% |
| 2025 | $51.86 Million | +231.97% |
| 2024 | $15.62 Million | -57.51% |
| 2023 | $36.77 Million | +199.00% |
| 2022 | $12.30 Million | -80.39% |
| 2021 | $62.70 Million | -31.24% |
| 2020 | $91.18 Million | -13.77% |
| 2019 | $105.74 Million | +93.96% |
| 2018 | $54.51 Million | +26.64% |
| 2017 | $43.05 Million | +22.94% |
| 2016 | $35.01 Million | +69.93% |
| 2015 | $20.61 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Nephros Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $32.46 Million USD |
| MoneyControl | $32.46 Million USD |
| MarketWatch | $32.46 Million USD |
| marketcap.company | $32.46 Million USD |
| Reuters | $32.46 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.